ITRM950573A0 - Procedimento per produrre - in forma pura ed in quantita' elevate- polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e metodologia per riprodurre e saggiare efficacemente in vitro l'attivi-ta' proteolitica dei suddetti polipeptidi - Google Patents

Procedimento per produrre - in forma pura ed in quantita' elevate- polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e metodologia per riprodurre e saggiare efficacemente in vitro l'attivi-ta' proteolitica dei suddetti polipeptidi

Info

Publication number
ITRM950573A0
ITRM950573A0 ITRM950573A ITRM950573A ITRM950573A0 IT RM950573 A0 ITRM950573 A0 IT RM950573A0 IT RM950573 A ITRM950573 A IT RM950573A IT RM950573 A ITRM950573 A IT RM950573A IT RM950573 A0 ITRM950573 A0 IT RM950573A0
Authority
IT
Italy
Prior art keywords
polypeptides
proteolytic activity
hcv
protease
methodology
Prior art date
Application number
ITRM950573A
Other languages
English (en)
Inventor
Antonello Pessi
Licia Tomei
Francesco Raffaele De
Original Assignee
Antonello Pessi
Licia Tomei
Francesco Raffaele De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11403536&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITRM950573(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Antonello Pessi, Licia Tomei, Francesco Raffaele De filed Critical Antonello Pessi
Priority to IT95RM000573A priority Critical patent/IT1277914B1/it
Publication of ITRM950573A0 publication Critical patent/ITRM950573A0/it
Priority to PT96926574T priority patent/PT846164E/pt
Priority to BR9610039A priority patent/BR9610039A/pt
Priority to JP51008297A priority patent/JP3310298B2/ja
Priority to PCT/IT1996/000163 priority patent/WO1997008304A2/en
Priority to ES96926574T priority patent/ES2236743T3/es
Priority to CN96196406A priority patent/CN1193997A/zh
Priority to AU66686/96A priority patent/AU716379B2/en
Priority to DE69634406T priority patent/DE69634406T2/de
Priority to EP96926574A priority patent/EP0846164B1/en
Priority to DK96926574T priority patent/DK0846164T3/da
Priority to AT96926574T priority patent/ATE290070T1/de
Priority to CA002228265A priority patent/CA2228265C/en
Publication of ITRM950573A1 publication Critical patent/ITRM950573A1/it
Publication of IT1277914B1 publication Critical patent/IT1277914B1/it
Application granted granted Critical
Priority to US09/011,961 priority patent/US6197536B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT95RM000573A 1995-08-22 1995-08-22 Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e IT1277914B1 (it)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IT95RM000573A IT1277914B1 (it) 1995-08-22 1995-08-22 Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e
CA002228265A CA2228265C (en) 1995-08-22 1996-08-20 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease
AU66686/96A AU716379B2 (en) 1995-08-22 1996-08-20 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the HCV NS3 protease
DE69634406T DE69634406T2 (de) 1995-08-22 1996-08-20 Verfahren zum In-Vitro-Texten der proteolytischen Aktivität von Polypeptiden mit HCV NS3 Protease-Aktivität sowie Peptidsubstrate, die in diesem Verfahren verwendet werden
JP51008297A JP3310298B2 (ja) 1995-08-22 1996-08-20 Ｈｃｖ ｎｓ３プロテアーゼのタンパク質分解活性を有するポリぺプチドを製造し、精製し、分析する方法
PCT/IT1996/000163 WO1997008304A2 (en) 1995-08-22 1996-08-20 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease
ES96926574T ES2236743T3 (es) 1995-08-22 1996-08-20 Procedimiento de ensayo in vitro de la actividad proteolitica de polipeptidos con actividad de proteasa hcv ns3 y peptidos sustratos a usar en dicho procedimiento.
CN96196406A CN1193997A (zh) 1995-08-22 1996-08-20 产生和纯化并测定具有hcvns3蛋白酶蛋白水解活性的多肽的方法
PT96926574T PT846164E (pt) 1995-08-22 1996-08-20 Metodologia para produzir, purificar e analisar polipeptidos com a actividade proteolitica da protease hcv ns3
BR9610039A BR9610039A (pt) 1995-08-22 1996-08-20 Polipeptídeos isolados vetores de expressão célula hospedeira processos para preparar um dos polipeptídeos e reproduzir e efetivamente ensaiar in vitro a atividade proteolitica da proteína NS3 do HCV peptídeos e depsipeptídeos
EP96926574A EP0846164B1 (en) 1995-08-22 1996-08-20 Method for assaying in vitro the proteolytic activity of polypeptides having hcv ns3 protease activity and peptide substrates to be used in this method.
DK96926574T DK0846164T3 (da) 1995-08-22 1996-08-20 Metodologi til fremstilling, oprensning og assay af polypeptider med den proteolytiske aktivitet af HCV NS3-protease
AT96926574T ATE290070T1 (de) 1995-08-22 1996-08-20 Verfahren zum in vitro testen der proteolytischen aktivität von polypeptiden mit hcv ns3 protease aktivität sowie peptidsubstrate, die in diesem verfahren verwendet werden
US09/011,961 US6197536B1 (en) 1995-08-22 1998-02-23 Methodology to produce, and purify and assay polypeptides with the proteolytic activity of the HCV NS3 protease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95RM000573A IT1277914B1 (it) 1995-08-22 1995-08-22 Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e

Publications (3)

Publication Number Publication Date
ITRM950573A0 true ITRM950573A0 (it) 1995-08-22
ITRM950573A1 ITRM950573A1 (it) 1997-02-22
IT1277914B1 IT1277914B1 (it) 1997-11-12

Family

ID=11403536

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95RM000573A IT1277914B1 (it) 1995-08-22 1995-08-22 Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e

Country Status (14)

Country Link
US (1) US6197536B1 (it)
EP (1) EP0846164B1 (it)
JP (1) JP3310298B2 (it)
CN (1) CN1193997A (it)
AT (1) ATE290070T1 (it)
AU (1) AU716379B2 (it)
BR (1) BR9610039A (it)
CA (1) CA2228265C (it)
DE (1) DE69634406T2 (it)
DK (1) DK0846164T3 (it)
ES (1) ES2236743T3 (it)
IT (1) IT1277914B1 (it)
PT (1) PT846164E (it)
WO (1) WO1997008304A2 (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1285158B1 (it) * 1996-09-17 1998-06-03 Angeletti P Ist Richerche Bio Polipeptidi solubili con l'attivita' di serino-proteasi di ns3 del virus dell'epatite c, e procedimento per la loro preparazione e il
GB9623908D0 (en) * 1996-11-18 1997-01-08 Hoffmann La Roche Amino acid derivatives
GB9707659D0 (en) * 1997-04-16 1997-06-04 Peptide Therapeutics Ltd Hepatitis C NS3 Protease inhibitors
ES2143918B1 (es) * 1997-05-23 2001-01-01 Inst Cientifico Tecnol Navarra Peptidos inhibidores de la proteasa c y su utilizacion en la preparacion de composiciones utiles en las infecciones causadas por el virus de la hepatitis c.
WO1999028482A2 (en) * 1997-11-28 1999-06-10 Schering Corporation Single-chain recombinant complexes of hepatitis c virus ns3 protease and ns4a cofactor peptide
IT1299134B1 (it) * 1998-02-02 2000-02-29 Angeletti P Ist Richerche Bio Procedimento per la produzione di peptidi con proprieta' inibitrici della proteasi ns3 del virus hcv, peptidi cosi' ottenibili e peptidi
WO2000001718A2 (en) * 1998-07-02 2000-01-13 University Of Florida Ns4a-ns3 catalytic domain of hepatitis c
US6323180B1 (en) * 1998-08-10 2001-11-27 Boehringer Ingelheim (Canada) Ltd Hepatitis C inhibitor tri-peptides
JP2002534084A (ja) 1999-01-08 2002-10-15 ブリストル−マイヤーズ スクイブ カンパニー Ｃ型肝炎ウイルスｎｓ３プロテアーゼの修飾形
CA2365262C (en) * 1999-05-04 2008-06-10 Boehringer Ingelheim (Canada) Ltd. Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease
WO2001016379A1 (en) * 1999-08-30 2001-03-08 Merck & Co., Inc. Hepatitis c virus replication inhibitors
GB0006537D0 (en) * 2000-03-17 2000-05-10 Angeletti P Ist Richerche Bio Assays and screening methods
MXPA03004835A (es) 2000-12-15 2005-04-19 Boehringer Ingelheim Ltd Proteasa ns2/3 activa, purificada de virus de hepatitis c.
CA2498653C (en) * 2002-10-29 2010-12-14 Boehringer Ingelheim International Gmbh Inhibitor-resistant hcv ns3 protease
US7834145B2 (en) 2005-03-22 2010-11-16 Merck Sharp & Dohme Corp. HCV protease substrates
CA2627247C (en) * 2005-10-28 2013-04-02 Boehringer Ingelheim International Gmbh Hepatitis c virus ns2/3 activity assay
CN103012565B (zh) * 2013-01-15 2014-07-16 成都天台山制药有限公司 一种曲普瑞林及其固相合成制备方法
JP6564539B1 (ja) * 2018-09-14 2019-08-21 長瀬産業株式会社 スルホン酸化合物によるペプチド精製方法
WO2025178073A1 (ja) * 2024-02-22 2025-08-28 天野エンザイム株式会社 タンパク質分解酵素が除去されたことを確認する方法及びその応用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133402T2 (de) * 1990-04-04 2004-11-11 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Protease von hepatitis-c-virus
WO1995011918A1 (en) * 1993-10-29 1995-05-04 Srl, Inc. Antigen peptide compound and immunoassay method
JPH08205893A (ja) * 1994-12-08 1996-08-13 Sumitomo Metal Ind Ltd Ｈｃｖプロテアーゼ活性測定法
US5767233A (en) * 1995-05-12 1998-06-16 Schering Corporation Soluble cleavable substrates of the hepatitis C virus protease

Also Published As

Publication number Publication date
BR9610039A (pt) 1999-07-06
AU716379B2 (en) 2000-02-24
JPH10511556A (ja) 1998-11-10
DE69634406T2 (de) 2006-04-13
ES2236743T3 (es) 2005-07-16
CN1193997A (zh) 1998-09-23
ITRM950573A1 (it) 1997-02-22
ATE290070T1 (de) 2005-03-15
US6197536B1 (en) 2001-03-06
WO1997008304A2 (en) 1997-03-06
IT1277914B1 (it) 1997-11-12
AU6668696A (en) 1997-03-19
PT846164E (pt) 2005-07-29
CA2228265C (en) 2002-08-13
JP3310298B2 (ja) 2002-08-05
DK0846164T3 (da) 2005-06-27
DE69634406D1 (de) 2005-04-07
CA2228265A1 (en) 1997-03-06
EP0846164B1 (en) 2005-03-02
WO1997008304A3 (en) 1997-05-22
EP0846164A2 (en) 1998-06-10

Similar Documents

Publication Publication Date Title
ITRM950573A0 (it) Procedimento per produrre - in forma pura ed in quantita' elevate- polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e metodologia per riprodurre e saggiare efficacemente in vitro l'attivi-ta' proteolitica dei suddetti polipeptidi
ITRM940092A0 (it) Metodologia per riprodurre in vitro l'attivita' proteolitica della proteasi ns3 del virus hcv.
IT1299134B1 (it) Procedimento per la produzione di peptidi con proprieta' inibitrici della proteasi ns3 del virus hcv, peptidi cosi' ottenibili e peptidi
DK1056883T3 (da) Gærcelleoverfladeprotein-display og anvendelser deraf
DE69832158D1 (de) Isolierung und strukturelle aufklärung der kryostatischen linearen und cyclo-depsipeptide dolastatin 16, dolastatin 17, und dolastatin 18
GB8817997D0 (en) Enzyme electrodes & improvements in manufacture thereof
DK1025240T3 (da) Fler-substituerede proteasevarianter med ændret nettoladning til anvendelse i detergenter
IS6181A (is) Ein- og tvíataðgengnar 3-própýl-gamma-amínósmjörsýrur
FI954504A7 (fi) Parannuksia fermentoitujen mallasjuomien valmistukseen
DE59611435D1 (de) Vakuumisolierter Kryobehälter
NO973551D0 (no) Indoler med brostruktur som matriksmetallproteaseinhibitorer
DK72493D0 (da) Solid supports for use in peptide synthesis and assays
IT1226551B (it) Peptide sintetico immunologicamente attivo capace di indurre la produzione di anticorpi con elevata specificita' verso l'alfa- fetoproteina e loro impiego in campo diagnostico
FI904258A7 (fi) Mitomysiini C:n stabiilit liuokset
FI955524A7 (fi) Kiinteinä liuoksina olevia valmisteita
ITMI931959A0 (it) Dispositivo di cortocircuitazione particolarmente per elettrolizzatorimono e bipolari e simili
FR2594845B1 (fr) Preparation par voie microbiologique de l'activateur tissulaire humain du plasminogene (t-pa) et conversion de l'enzyme ainsi obtenue en sa forme active
ITMI972556A1 (it) Procedimento e mezzi atti al miglioramento delle bevande in genere per effetto della loro edulcorazione al momento della consumazione
ZA95454B (en) A novel protein from aedes albopictus cells and methods for its use
FR2731531B1 (fr) Montre notamment du type montre-bracelet
DE60116474D1 (de) Hcv ns2/3 fragmente und ihre verwendungen
IT1238207B (it) Preparato vitaminizzato contenente l'enzima lisozima impiegabile in zootecnica e procedimento per la sua produzione.
EP0749170A3 (en) Hydrogen absorbing alloy and electrode made of this material
DE69412664D1 (de) Wasserstoffspeichernde Legierung und Elektrode daraus
KR970702935A (ko) 수소흡장합금 및 상기 합금으로 만들어진 전극(hydrogen occluding alloy and electrode made of the alloy)

Legal Events

Date Code Title Description
0001 Granted